Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Withdrawal in Renal Transplant Patients
NCT01292525Phase 3Terminated
- Sponsor
- CHU de Nantes
- Start
- May 2011
- Primary completion
- May 2015
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in renal transplant rejection (RTR), sponsored by CHU de Nantes. Started May 2011; status: terminated.
02
Drugs
tacrolimus
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT01292525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01292525.